|Bid||5.42 x 800|
|Ask||5.46 x 1200|
|Day's range||5.18 - 5.61|
|52-week range||2.60 - 14.98|
|Beta (5Y monthly)||2.28|
|PE ratio (TTM)||N/A|
|Earnings date||28 Jul 2021 - 02 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||10.00|
BLKB, CTXS, EKSO, FHI, and GCI have been added to the Zacks Rank #5 (Strong Sell) List on May 5, 2021
Ekso Bionics (EKSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ekso Bionics (EKSO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.